Philogen Spa announced Monday that it had purchased 2,185 of its own ordinary shares between March 13 and March 17. The shares were taken over at an average unit price of EUR15.7088, for a total. | March 20, 2023
Philogen Spa reported on Monday that it purchased 2,878 of its own ordinary shares between Jan. 16 and Jan. 20. The shares were taken over at an average unit price of EUR14.0056, for a total value of. | January 23, 2023
Philogen Spa announced Tuesday that it had purchased 2,332 of its own ordinary shares between Dec. 19 and Dec. 23. The shares were taken over at an average unit price of EUR14.2020, for a total value. | December 27, 2022
Philogen Provides Corporate Update 211 out of 214 patients recruited in European Phase III trial investigating the neoadjuvant Nidlegy treatment of Stage IIIB/C melanoma, in line with expectations.Fibromun further